Stockholm - Free Realtime Quote SEK
Active Biotech AB (publ) (ACTI.ST)
As of 11:06 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
--
--
--
--
6,725.0000
--
Operating Expense
44,784.0000
46,484.0000
57,886.0000
49,782.0000
39,031.0000
--
Operating Income
-44,784.0000
-46,484.0000
-57,886.0000
-49,782.0000
-32,306.0000
--
Net Non Operating Interest Income Expense
-53.0000
47.0000
-156.0000
-26.0000
-87.0000
--
Pretax Income
-44,200.0000
-45,800.0000
-58,372.0000
-49,825.0000
-32,245.0000
--
Net Income Common Stockholders
-44,200.0000
-45,800.0000
-58,372.0000
-49,825.0000
-32,245.0000
--
Diluted NI Available to Com Stockholders
-44,200.0000
-45,800.0000
-58,372.0000
-49,825.0000
-32,245.0000
--
Basic EPS
-0.14
-0.17
-0.25
-0.21
-0.16
--
Diluted EPS
-0.14
-0.17
-0.25
-0.21
-0.16
--
Basic Average Shares
319,877.1250
271,524.6250
233,651.5790
238,065.8740
195,465.2530
--
Diluted Average Shares
319,877.1250
271,524.6250
233,651.5790
238,065.8740
195,465.2530
--
Total Operating Income as Reported
-44,784.0000
-46,484.0000
-57,886.0000
-49,782.0000
-32,306.0000
--
Total Expenses
44,784.0000
46,484.0000
57,886.0000
49,782.0000
39,031.0000
--
Net Income from Continuing & Discontinued Operation
-44,200.0000
-45,800.0000
-58,372.0000
-49,825.0000
-32,245.0000
--
Normalized Income
-44,766.0000
-46,366.0000
-58,052.0000
-49,793.0000
-32,460.0000
--
Interest Income
--
285.0000
49.0000
--
--
--
Interest Expense
--
238.0000
205.0000
26.0000
87.0000
--
Net Interest Income
-53.0000
47.0000
-156.0000
-26.0000
-87.0000
--
EBIT
-43,862.0000
-45,562.0000
-58,167.0000
-49,799.0000
-32,158.0000
--
EBITDA
-43,862.0000
-43,887.0000
-56,672.0000
-48,521.0000
-30,838.0000
--
Reconciled Depreciation
--
1,675.0000
1,495.0000
1,278.0000
1,320.0000
--
Net Income from Continuing Operation Net Minority Interest
-44,200.0000
-45,800.0000
-58,372.0000
-49,825.0000
-32,245.0000
--
Total Unusual Items Excluding Goodwill
566.0000
566.0000
-320.0000
-32.0000
215.0000
--
Total Unusual Items
566.0000
566.0000
-320.0000
-32.0000
215.0000
--
Normalized EBITDA
-44,428.0000
-44,453.0000
-56,352.0000
-48,489.0000
-31,053.0000
--
12/31/2019 - 12/19/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1854
+0.76%
WNT.ST WntResearch AB
0.8980
-0.22%
NICA.ST Nanologica AB (publ)
2.3400
-1.27%
DIABIO.ST Diagonal Bio AB (publ)
0.0369
-4.90%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2170
+20.56%
FLUI.ST Fluicell AB (publ)
0.0758
+2.99%
XSPRAY.ST Xspray Pharma AB (publ)
62.90
+3.45%
ONCO.ST Oncopeptides AB (publ)
2.0900
+0.24%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
0.9180
+2.46%
SPRO Spero Therapeutics, Inc.
1.2800
-0.39%